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IN recent work in this laboratory it was shown that an extract of flue-cured
cigarette tobacco leaf (WTE) as well as cigarette smoke condensate (WCT)
exhibit tumor-promoting activity (Van Duuren et al., 1966). In these experiments
a single dose of 7,12-dimethylbenz[a]anthracene (DMBA) was applied on mouse
skin as initiator followed by repeated skin application of the promoting agents.
While this procedure proved satisfactory for bioassay of a number of fractions
and subfractions derived from tobacco leaf and tars, it was desirable also to
explore systemic treatment with several initiating agents followed by skin appli-
cation of the promoting agents. The present report describes the bioassay of
several promoting agents with DMBA, benzo[a]pyrene (BP) and urethane as
initiators. The initiators were given by subcutaneous and intraperitoneal injec-
tion in mice; the promoting agents were applied on skin. The results of these
experiments are compared with our earlier results, in which both the initiator and
promoter were applied on mouse skin (Van Duuren and Orris, 1965; Van Duuren
et al., 1966).
MATERIAL.S AND METHODS
The test animals were female HA/ICR Swiss mice and 20 animals were used
per group. The initiators used in these experiments were DMBA at several
dosages (0.5-500 jug.), BP and urethane, each at 1 dosage level; 0-5 mg., and
20 mg. respectively. The initiators were injected in tricaprylin or saline with a
26 gauge, 3 in. needle, in a single dose, either subcutaneously on the left flank or
intraperitoneally on the left side of the abdomen. The promoters used were
croton resin (CR), whole tobacco extract (WTE), and whole cigarette tar (WCT).
The methods of preparation of these materials were described in our earlier
reports (Van Duuren and Orris, 1965; Van Duuren et al., 1966). The dosages
and solvents used were as follows: CR: 25 ,ug./0 1 ml. acetone; WTE: 25 mg./0.1
ml. acetone-water (1 : 1); WCT: 25 mg./0 1 ml. acetone. Promoters were
applied to the clipped dorsal skin 3 times weekly with a No. 5 squirrel hair brush
delivering close to 100 mg. of solution per application. Promotion treatments
were started 2 weeks after initiation. In a few experiments a longer interval was
allowed to elapse between initiation and promotion, and these are indicated under
results.
Included in the test series were the following control groups: animals that
received initiator only, promoter only, solvent controls, and groups which received
no treatment.TUMOUR PROMOTION AND TOBACCO PRODUCTS
RESULTS
The yield of skin tumors resulting from the various treatments is shown in
Tables I and II.
Local tumors were not observed in groups injected subcutaneouslv with either
20 mg. urethane or 0*5 ,ug. DMBA, although these doses were quite effective for
the induction of skin tumors. The injection of 0 5 mg. of DMBA or BP resulted
in fibrosarcomas at the injection site in 70-95 % of the mice with about 10 % of
these tumors having overlying squamous carcinomas. Early deaths due to these
malignancies may account for the absence of skin carcinomas in these groups.
Higher doses of DMBA yielded increased numbers of local tumors similar to the
results observed by others (Hieger, 1965). On the other hand, intraperitoneal
injection ofthe initiators did not cause local tumors in any ofthe groups so treated.
Skin tumors were not observed in any of the control groups except the one
that received croton resin only. The response of this group is shown in Table II.
DISCUSSION
Gastric intubation of DMBA and some other polycyclic hydrocarbons followed
by skin application of croton oil was shown to be effective for skin tumour induc-
tion by Berenblum and Haran-Ghera (1957). In our experiments using other
routes of systemic initiation, the number of papilloma-bearing mice per group
receiving promoting agents clearly indicates that DMBA is a potent initiator for
skin tumor induction when given either by intraperitoneal or subcutaneous
injection. However, systemic initiation with BP (500p/g.) followed by skin
promotion yielded very few tumors in the area ofapplication ofthe promoter with
all three promoting agents used. The latent period with BP as initiator was
much longer than with the same dose of DMBA for both routes of administration
of the initiator. These results indicate that BP is not effective as a systemic
initiator at the dose used in this study. Poel (1963) found that BP was not
carcinogenic for mouse skin following gastric administration of the carcinogen,
whereas, 3-methylcholanthrene and DMBA administered under the same condi-
tions resulted in skin cancers. It has also been reported that DMBA is markedly
less active than BP in the induction of rat liver BP-hydroxylase (Conney et al.,
1957). The difference in metabolic patterns of the hydrocarbons probably plays
a significant role in determining the ability ofhydrocarbons to act as initiators for
skin tumor induction when administered systemically.
The permanent nature ofthe initiating action ofurethane was clearly shown by
the experiments in which the promoting treatment with CR was delayed for 246
days. In these experiments similar results were obtained with both intraperi-
toneal and subcutaneous injections ofurethane. The incidence ofpapillomas was
compared at 210 days after the beginning of promoting treatment in the groups
where promotion was delayed for 14 days and for 246 days. The period 210
days was selected because after this time interval papillomas coalesce and are
difficult to score; furthermore, in the experiment in which the interval was 246
days, animal mortality was increasing. The data at 210 days after the beginning
ofpromotion are not reflected in the tables and are as follows: in the group given
subcutaneous injection of urethane, there were 12 tumors in 7 animals in the
delayed promotion group and 5 tumors in 5 animals in the group in which the
interval was 14 days. Similarly, following intraperitoneal injection of urethane,
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comparable tumor yields were 18 tumors in 8 animals with delayed promotion
and 10 tumors in 6 animals with the usual interval of 14 days. Although the
tumor yields with delayed promotion appear to be larger than in experiments with
a 14 day interval between initiation and promotion, a statistical evaluation
(x2) of the data from these small test groups showed no significant differences
between the two series.
On the other hand, in the experiment with urethane initiation and CR promo-
tion, the latent period, i.e., the interval between the beginning of promoting
treatment and first appearance of papillomas, was substantially shorter in groups
where the promoting treatment was started after an 8 month interval. The times
to first tumors, 32 and 42 days (Tables I and II), in the delayed promotion experi-
ments, are similar to those observed for skin initiation with DMBA followed by
promotion with CR. Longer latent periods, 63 and 97 days respectively, were
found in the groups where promoting treatment was started 11 days after systemic
initiation.
The experiments described here indicate that for the bioassay of potential
promoting agents, skin application ofthe initiating agent is preferable to systemic
initiation, both in terms oftime to first tumor and final tumor yields.
SUMMARY
A study was made of the promoting activity of phorbol esters from Croton
tiglium L., tobacco leafextract and cigarette tar following systemic initiation with
DMBA, urethane or BP given by a single subcutaneotus or intraperitoneal injection.
DMBA was shown to be a potent systemic initiator at doses even as low as
5 ,tg., while BP at 500 ,ag. was ineffective as a systemic initiator for skin tumors.
The permanent nature ofsuch systemic initiation was shown in experiments in
which skin tumors were induced when promoting treatment was delayed for 246
days. In these experiments there was no diminution in tumor yield and the latent
period was shorter when compared to experiments in which the interval was 14
days.
WTE and WCT were active tumor-promoting agents on mouse skin when the
initiating agent was given systemically. The latent period, however, was longer
and the tumor yields lower than in corresponding experiments in which CR was
used as a promoter.
For the purpose of bioassay of potential promoting agents, skin application of
the initiator is preferable to systemic initiation.
This work was supported by Contract PH43-64-938, grants CA-06989 from
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